Brand name · Ophthalmic / Anti-VEGF
Eylea (Aflibercept) J-Code / HCPCS Code
In short
Eylea is billed under HCPCS J0178 — Injection, aflibercept, 1 mg. One billing unit is 1 mg.
EYLEA HD has its own HCPCS code.
Reference
- Code
- J0178 — Injection, aflibercept, 1 mgMed-Code curated
- Billing unit
- 1 mg
- Same code in the directory
- Aflibercept
- Pharmacologic class
- Vascular Endothelial Growth Factor InhibitorFrom the FDA listings below
- J-code category
- Ophthalmic / Anti-VEGF
FDA-listed products
Finished products whose name and route match this directory entry.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Eyleaaflibercept | Aflibercept 40 mg/mL | Injection, SolutionIntravitreal | Regeneron Pharmaceuticals, Inc. | 61755-005 |
Other products with this name
Same name but a different route, formulation or combination — the code above does not apply to these.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Eylea HDaflibercept | Aflibercept 8 mg/.07mL | Injection, SolutionIntravitreal | Regeneron Pharmaceuticals, Inc | 61755-050 |
| Eylea HDaflibercept | Aflibercept 8 mg/.07mL | Injection, SolutionIntravitreal | Regeneron Pharmaceuticals, Inc | 61755-051 |
NDCs billed under J0178
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 2 NDCs to J0178 for Eylea. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Eylea | 61755-0005-01 | Regeneron Pharmaceuticals, Inc. | 0.05 | 2 |
| Eylea | 61755-0005-02 | Regeneron Pharmaceuticals, Inc. | 0.05 | 2 |